Tillbaka till portföljen
IPDx OU
MedTechImmunoprofiling diagnostics for personalized treatment decisions.
ImmunologyDiagnosticsPrecision MedicineOncology
Investerat
2020
Grundat
2018
Huvudkontor
Tallinn, Estonia
Sektor
MedTech
Om
IPDx developed immunoprofiling diagnostics technology that analyzed patients' immune system responses to guide personalized treatment decisions. The platform aimed to improve outcomes in oncology and infectious disease management through precision immunology.